A detailed history of Atlanta Consulting Group Advisors, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Atlanta Consulting Group Advisors, LLC holds 3,757 shares of BSX stock, worth $340,609. This represents 0.08% of its overall portfolio holdings.

Number of Shares
3,757
Previous 3,200 17.41%
Holding current value
$340,609
Previous $246 Million 27.76%
% of portfolio
0.08%
Previous 0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$72.96 - $84.0 $40,638 - $46,788
557 Added 17.41%
3,757 $315 Million
Q1 2024

May 13, 2024

BUY
$57.6 - $68.62 $184,320 - $219,584
3,200 New
3,200 $219 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $130B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Atlanta Consulting Group Advisors, LLC Portfolio

Follow Atlanta Consulting Group Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlanta Consulting Group Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlanta Consulting Group Advisors, LLC with notifications on news.